• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于预防呼吸道感染的鼻喷雾剂干预措施的定性过程评估。

A qualitative process evaluation of a nasal spray intervention to prevent respiratory tract infections.

作者信息

Dennis Amelia, Joseph Judith, Greenwell Kate, Miller Sascha, Vennik Jane, Dennison Laura, Holt Sian, Bradbury Katherine, Geraghty Adam W A, Little Paul, Yardley Lucy

机构信息

School of Psychology, University of Southampton, Southampton, United Kingdom.

Primary Care Research Centre, University of Southampton, Southampton, United Kingdom.

出版信息

PLoS One. 2025 Apr 29;20(4):e0321314. doi: 10.1371/journal.pone.0321314. eCollection 2025.

DOI:10.1371/journal.pone.0321314
PMID:40299893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040087/
Abstract

Nasal sprays could be used to prevent and manage respiratory tract infections (RTIs). As part of a randomized controlled trial (ISRCTN17936080), participants received one of two nasal sprays (gel-based vs. saline) and a digital intervention. The digital intervention used behaviour change theories to encourage nasal spray use to reduce the severity and occurrences of RTIs. We explored participants' experiences of the digital intervention and nasal spray. We interviewed 31 participants (aged 19-80), sampled from the two nasal spray intervention trial arms across 3 winter seasons (including at the height of COVID-19). We analysed the interviews using thematic analysis and found two themes regarding facilitators and barriers to nasal spray use. The facilitators of nasal spray use revolved around belief in nasal spray efficacy for infection, belief the nasal spray is safe, motivation to avoid infection, sense of control over infection, and how the nasal spray is integrated into lifestyle. Barriers to nasal spray use included the belief the nasal spray is ineffective, belief the nasal spray is unnecessary, and usage difficulties. Overall, the results highlight the role of beliefs, lifestyle integration, and usage difficulties in nasal spray adherence, with implications for future digital interventions, such as addressing concerns about the nasal spray being perceived as medication.

摘要

鼻喷雾剂可用于预防和管理呼吸道感染(RTIs)。作为一项随机对照试验(ISRCTN17936080)的一部分,参与者接受了两种鼻喷雾剂(凝胶型与盐水型)之一以及一种数字干预措施。该数字干预措施运用行为改变理论来鼓励使用鼻喷雾剂,以减轻呼吸道感染的严重程度并减少其发生频率。我们探究了参与者对数字干预措施和鼻喷雾剂的体验。我们采访了31名参与者(年龄在19至80岁之间),他们来自两个鼻喷雾剂干预试验组,跨越了3个冬季(包括新冠疫情高峰期)。我们采用主题分析法对访谈进行了分析,发现了关于鼻喷雾剂使用的促进因素和障碍的两个主题。鼻喷雾剂使用的促进因素围绕着对鼻喷雾剂预防感染功效的信念、对鼻喷雾剂安全性的信念、避免感染的动机、对感染的控制感以及鼻喷雾剂如何融入生活方式。鼻喷雾剂使用的障碍包括认为鼻喷雾剂无效、认为鼻喷雾剂不必要以及使用困难。总体而言,研究结果凸显了信念、生活方式融入以及使用困难在鼻喷雾剂依从性方面的作用,这对未来的数字干预措施具有启示意义,比如解决对鼻喷雾剂被视为药物的担忧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/25637a003d6b/pone.0321314.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/3486a98dbd1e/pone.0321314.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/de201922c3f9/pone.0321314.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/25637a003d6b/pone.0321314.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/3486a98dbd1e/pone.0321314.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/de201922c3f9/pone.0321314.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf9/12040087/25637a003d6b/pone.0321314.g003.jpg

相似文献

1
A qualitative process evaluation of a nasal spray intervention to prevent respiratory tract infections.一项关于预防呼吸道感染的鼻喷雾剂干预措施的定性过程评估。
PLoS One. 2025 Apr 29;20(4):e0321314. doi: 10.1371/journal.pone.0321314. eCollection 2025.
2
Using nasal sprays to prevent respiratory tract infections: a qualitative study of online consumer reviews and primary care patient interviews.使用鼻腔喷雾剂预防呼吸道感染:对在线消费者评论和初级保健患者访谈的定性研究。
BMJ Open. 2022 Jun 30;12(6):e059661. doi: 10.1136/bmjopen-2021-059661.
3
Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial.在初级保健中,鼻喷雾剂和行为干预与常规护理治疗急性呼吸道疾病的比较:一项随机、对照、开放标签、平行组试验。
Lancet Respir Med. 2024 Aug;12(8):619-632. doi: 10.1016/S2213-2600(24)00140-1. Epub 2024 Jul 11.
4
Determining the clinical and cost-effectiveness of nasal sprays and a physical activity and stress management intervention to reduce respiratory tract infections in primary care: A protocol for the 'Immune Defence' randomised controlled trial.确定鼻喷雾剂和身体活动与压力管理干预措施在初级保健中减少呼吸道感染的临床和成本效益:“免疫防御”随机对照试验方案。
PLoS One. 2023 Jul 14;18(7):e0285693. doi: 10.1371/journal.pone.0285693. eCollection 2023.
5
Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.聚维酮碘对鼻咽部 COVID-19 的病毒杀灭效果:一项开放标签随机临床试验研究方案的结构化总结。
Trials. 2021 Jan 4;22(1):2. doi: 10.1186/s13063-020-04963-2.
6
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.阿昔洛韦钠抗病毒鼻喷剂用于减少呼吸道感染,在一项随机对照试验中具有安全性和良好的耐受性。
Sci Rep. 2022 Jun 17;12(1):10210. doi: 10.1038/s41598-022-14601-3.
7
Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial.阿扎司汀鼻喷雾剂用于非住院轻度新型冠状病毒肺炎感染患者:一项随机、安慰剂对照、平行组、多中心II期临床试验。
Viruses. 2024 Dec 13;16(12):1914. doi: 10.3390/v16121914.
8
The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.聚维酮碘鼻腔喷雾对鼻咽 SARS-CoV-2 病毒载量的影响:一项随机对照试验。
Laryngoscope. 2022 Nov;132(11):2089-2095. doi: 10.1002/lary.29935. Epub 2021 Nov 9.
9
[Results of an open, randomized, actively controlled study of the efficacy and safety of the new drug Freinozole nasal spray (Phenylephrine + Cetyrizine) in patients with acute respiratory infection].[新药Freinozole鼻喷雾剂(去氧肾上腺素+西替利嗪)治疗急性呼吸道感染患者有效性和安全性的开放性、随机、阳性对照研究结果]
Vestn Otorinolaringol. 2019;84(5):61-67. doi: 10.17116/otorino20198405161.
10
A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID.一项针对 COVID-19 预防的卡拉胶鼻喉喷雾的双盲随机安慰剂对照试验的研究方案——ICE-COVID。
Trials. 2022 Sep 15;23(1):782. doi: 10.1186/s13063-022-06685-z.

本文引用的文献

1
Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial.在初级保健中,鼻喷雾剂和行为干预与常规护理治疗急性呼吸道疾病的比较:一项随机、对照、开放标签、平行组试验。
Lancet Respir Med. 2024 Aug;12(8):619-632. doi: 10.1016/S2213-2600(24)00140-1. Epub 2024 Jul 11.
2
Acceptability of aspirin for cancer preventive therapy: a survey and qualitative study exploring the views of the UK general population.阿司匹林用于癌症预防治疗的可接受性:一项调查和定性研究,旨在探讨英国普通民众的观点。
BMJ Open. 2023 Dec 18;13(12):e078703. doi: 10.1136/bmjopen-2023-078703.
3
Old foes following news ways?-Pandemic-related changes in the epidemiology of viral respiratory tract infections.
旧敌追寻新途径?-病毒呼吸道感染流行病学与大流行相关的变化。
Infection. 2024 Feb;52(1):209-218. doi: 10.1007/s15010-023-02085-w. Epub 2023 Aug 29.
4
Determining the clinical and cost-effectiveness of nasal sprays and a physical activity and stress management intervention to reduce respiratory tract infections in primary care: A protocol for the 'Immune Defence' randomised controlled trial.确定鼻喷雾剂和身体活动与压力管理干预措施在初级保健中减少呼吸道感染的临床和成本效益:“免疫防御”随机对照试验方案。
PLoS One. 2023 Jul 14;18(7):e0285693. doi: 10.1371/journal.pone.0285693. eCollection 2023.
5
Global burden of lower respiratory infections during the last three decades.过去三十年下呼吸道感染的全球负担。
Front Public Health. 2023 Jan 9;10:1028525. doi: 10.3389/fpubh.2022.1028525. eCollection 2022.
6
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
7
The WHO estimates of excess mortality associated with the COVID-19 pandemic.世界卫生组织对 COVID-19 大流行相关超额死亡人数的估计。
Nature. 2023 Jan;613(7942):130-137. doi: 10.1038/s41586-022-05522-2. Epub 2022 Dec 14.
8
Using nasal sprays to prevent respiratory tract infections: a qualitative study of online consumer reviews and primary care patient interviews.使用鼻腔喷雾剂预防呼吸道感染:对在线消费者评论和初级保健患者访谈的定性研究。
BMJ Open. 2022 Jun 30;12(6):e059661. doi: 10.1136/bmjopen-2021-059661.
9
Economic Burden of COVID-19: A Systematic Review.新型冠状病毒肺炎的经济负担:一项系统综述
Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307. doi: 10.2147/CEOR.S338225. eCollection 2022.
10
Patient perceptions of vulnerability to recurrent respiratory tract infections and prevention strategies: a qualitative study.患者对反复呼吸道感染易感性和预防策略的看法:一项定性研究。
BMJ Open. 2022 Apr 20;12(4):e055565. doi: 10.1136/bmjopen-2021-055565.